|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||||||||
| Noninterest-bearing cash equivalents | |||||||||||||||||||
| Interest-bearing deposits with other institutions | |||||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||||
| Certificates of deposit with other banks | |||||||||||||||||||
| Securities available for sale, at fair value | |||||||||||||||||||
| Securities held to maturity (Fair value of $25,211 and $30,284, respectively) | |||||||||||||||||||
| Less: Allowance for credit losses - securities | |||||||||||||||||||
| Securities held to maturity, net | |||||||||||||||||||
| Loans receivable | |||||||||||||||||||
| Less: Allowance for credit losses - loans | |||||||||||||||||||
| Net loans | |||||||||||||||||||
| Investments in restricted bank stock | |||||||||||||||||||
| Premises and equipment, net | |||||||||||||||||||
| Right-to-Use Asset – Premises | |||||||||||||||||||
| Right-to-Use Asset - Premises | |||||||||||||||||||
| Bank-owned life insurance | |||||||||||||||||||
| Goodwill and other intangible assets | |||||||||||||||||||
| Goodwill | |||||||||||||||||||
| Other intangible assets, net | |||||||||||||||||||
| Deferred tax asset | |||||||||||||||||||
| Assets held for sale | |||||||||||||||||||
| Accrued interest receivable and other assets | |||||||||||||||||||
| TOTAL ASSETS | |||||||||||||||||||
| LIABILITIES | |||||||||||||||||||
| Deposits: | |||||||||||||||||||
| Demand, noninterest bearing | |||||||||||||||||||
| Interest bearing | |||||||||||||||||||
| Total deposits | |||||||||||||||||||
| Other borrowings | |||||||||||||||||||
| Long-term borrowings | |||||||||||||||||||
| Short-term borrowings | |||||||||||||||||||
| Note payable | |||||||||||||||||||
| Subordinated debt | |||||||||||||||||||
| Operating lease liabilities | |||||||||||||||||||
| Lease liabilities | |||||||||||||||||||
| Allowance for credit losses - unfunded commitments | |||||||||||||||||||
| Liabilities held for sale | |||||||||||||||||||
| Accrued interest payable and other liabilities | |||||||||||||||||||
| TOTAL LIABILITIES | |||||||||||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||||||||||
| Common stock (At December 31, 2025 and December 31, 2024: $0.01 par value; 50,000,000 shares authorized; 37,457,914 and 37,370,917 shares issued and outstanding, respectively.) | |||||||||||||||||||
| Surplus | |||||||||||||||||||
| Retained earnings | |||||||||||||||||||
| Accumulated other comprehensive loss | |||||||||||||||||||
| Total equity attributable to parent | |||||||||||||||||||
| Noncontrolling interest in consolidated subsidiary | |||||||||||||||||||
| TOTAL SHAREHOLDERS' EQUITY | |||||||||||||||||||
| TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | |||||||||||||||||||
Loading...
